Peter McWilliams's Colleagues at Glycomine
Peter McWilliams's Contact Details
HQ
650-401-2016
650-401-2016
Location
San Francisco,California,United States
San Francisco,California,United States
Company
Glycomine
Glycomine
Peter McWilliams's Company Details
Glycomine is developing orphan drugs for serious rare disorders of metabolism and protein misfolding for which no other therapeutic options exist. The company's approach is to use replacement therapies – substrates, enzymes, or proteins – and to target those molecules to clinically relevant cellular compartments. Glycomine's lead drug candidate, GLM101, is a novel substrate replacement therapy in development to treat phosphomannomutase 2-congenital disorder of glycosylation (PMM2-CDG), a rare disease representing a critical unmet medical need.
Frequently Asked Questions about Peter McWilliams
Peter McWilliams currently works for Glycomine Inc..
Peter McWilliams's role at Glycomine Inc. is Chief Business Officer.
Peter McWilliams's email address is ***@glycomine.com. To view Peter McWilliams's full email address, please signup to ConnectPlex.
Peter McWilliams works in the Research industry.
Peter McWilliams's colleagues at Glycomine are Geoffrey Hird, Horacio Plotkin, Teppei Shirakura, Steven Axon, Tristen Moors, Karen Morici, Helen Shapiro and others.
Peter McWilliams's phone number is 650-401-2016